Education
About Us
Working with TipRanks
Follow Us
Sensei Biotherapeutics (SNSE)
NASDAQ:SNSE
Total Valuation
Sensei Biotherapeutics has a market cap or net worth of $9.43M. The enterprise value is $2.15M.
Market Cap$9.43M
Enterprise Value$2.15M
Share Statistics
Sensei Biotherapeutics has 1,260,403 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,260,403
Owned by Insiders31.23%
Owned by Institutions3.38%
Financial Efficiency
Sensei Biotherapeutics’s return on equity (ROE) is -0.79 and return on invested capital (ROIC) is -77.23%.
Return on Equity (ROE)-0.79
Return on Assets (ROA)-0.66
Return on Invested Capital (ROIC)-77.23%
Return on Capital Employed (ROCE)-0.82
Revenue Per Employee0.00
Profits Per Employee-2.15M
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio5.51
Price to Fair Value0.32
Price to FCF-0.36
Price to Operating Cash Flow-7.30
PEG Ratio-1.46
Income Statement
In the last 12 months, Sensei Biotherapeutics had revenue of 0.00 and earned -30.16M in profits. Earnings per share was -1.20.
Revenue0.00
Gross Profit0.00
Operating Income-32.61M
Pretax Income-30.16M
Net Income-30.16M
EBITDA-32.61M
Earnings Per Share (EPS)-1.20
Cash Flow
In the last 12 months, operating cash flow was -1.65M and capital expenditures -44.00K, giving a free cash flow of -1.70M billion.
Operating Cash Flow-1.65M
Free Cash Flow-1.70M
Free Cash Flow per Share-1.34
Dividends & Yields
Sensei Biotherapeutics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.12
52-Week Price Change-42.90%
50-Day Moving Average7.43
200-Day Moving Average8.78
Relative Strength Index (RSI)47.29
Average Volume (3m)10.46K
Important Dates
Sensei Biotherapeutics upcoming earnings date is Nov 11, 2025, Before Open (Confirmed).
Last Earnings DateJul 31, 2025
Next Earnings DateNov 11, 2025
Ex-Dividend Date―
Financial Position
Sensei Biotherapeutics as a current ratio of 7.70, with Debt / Equity ratio of 10.03%
Current Ratio7.70
Quick Ratio7.70
Debt to Market Cap0.19
Net Debt to EBITDA0.19
Interest Coverage Ratio-362.38
Taxes
In the past 12 months, Sensei Biotherapeutics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Sensei Biotherapeutics EV to EBITDA ratio is -0.19, with an EV/FCF ratio of -0.25.
EV to Sales0.00
EV to EBITDA-0.19
EV to Free Cash Flow-0.25
EV to Operating Cash Flow-0.25
Balance Sheet
Sensei Biotherapeutics has $34.33M in cash and marketable securities with $3.21M in debt, giving a net cash position of -$31.12M billion.
Cash & Marketable Securities$34.33M
Total Debt$3.21M
Net Cash-$31.12M
Net Cash Per Share-$24.69
Tangible Book Value Per Share$1.53
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Sensei Biotherapeutics is $67.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$67.50
Price Target Upside802.41% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast1.00%